Login
$CYPH
$1.92 -$0.01 (0.26%) After hours

Company Executives

Officer Age 2025 pay Source
Douglas E. Onsi Also a director
CEO,CFO,Pres.,GC,Treas.&Sec.
Title from the Form 4 dated Jul 1, 2026
57 $4,744,255
William Patrick McEvoy III
Chief Investment Officer
Title from the Form 4 dated Oct 12, 2026
Not stated Not reported
Kevin Zhang
Head of Mining
Title from the Form 4 dated Aug 21, 2026
Not stated Not reported
Will McEvoy Also a director
Executive officer
30 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 29, 2026 · updated by the 8-K of Sep 22, 2026

Directors
13
serving now
Independent
3 of 3
stated in the proxy; 10 not stated
Average tenure
7.6 years
from year joined
CEO also chairs the board
No
Khing Oei and Christopher Mirabelli
Director Age On board Independent Committees Other public boards 2025 pay Source
Khing Oei
50 Not stated Not stated None stated None stated $6,578,111
Douglas E. Onsi
57 2020
6 years
Not stated None stated None stated Paid as CEO
Thomas Dietz
62 2016
10 years
Not stated None stated None stated $267,123
Will McEvoy
30 2026
this year
Not stated None stated None stated Not stated
Nissim Mashiach
65 2017
9 years
Independent
Audit Committee Nominating and Corporate Governance Committee
Mediwound Ltd. $198,660
Christian Richard
56 2023
3 years
Independent
Audit Committee Nominating and Corporate Governance Committee
None stated $198,660
William Li
63 2017
9 years
Not stated None stated None stated $203,660
Patricia Martin
Not stated Not stated Independent None stated None stated $203,660
Amanda Fabiano Joined Sep 22, 2026
- - - - - -
Joseph Loscalzo Leaving at the meeting
74 2016
10 years
Not stated
Nominating and Corporate Governance Committee
Ionis Pharmaceuticals, Inc. $194,160
Christopher Mirabelli Leaving at the meeting
71 2011
15 years
Not stated None stated None stated Not stated
James Cavanaugh Leaving at the meeting
89 2016
10 years
Not stated
Nominating and Corporate Governance Committee · Chair Audit Committee
None stated $208,660
Richard Schilsky Leaving at the meeting
75 2022
4 years
Not stated
Nominating and Corporate Governance Committee
None stated $194,160

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support